Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial*

OBJECTIVE: The purpose of this study was to investigate if the levonorgestrel-impregnated intrauterine device (LNG-IUS, Mirena®) is safe and effective as therapy for low-risk and medium-risk endometrial hyperplasia compared with oral medroxyprogesterone (MPA). DESIGN: A multicentre randomised trial....

Descripción completa

Detalles Bibliográficos
Autores principales: Ørbo, A, Vereide, AB, Arnes, M, Pettersen, I, Straume, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Gynaecological Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155866/
https://www.ncbi.nlm.nih.gov/pubmed/24286192
http://dx.doi.org/10.1111/1471-0528.12499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155866/
https://www.ncbi.nlm.nih.gov/pubmed/24286192
http://dx.doi.org/10.1111/1471-0528.12499

Ejemplares similares